Support for Your
Path Forward with
Abeona Assist
Access information and support for those considering ZEVASKYN™ (prademagene zamikeracel), an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Whether you are exploring ZEVASKYN, have questions, or are ready to take the next steps, Patient Navigators at Abeona Assist are here to guide you along the journey.
Get Help Navigating the ZEVASKYN Treatment Pathway
Get paired with an Abeona Assist Patient Navigator, your dedicated contact to help you understand the ZEVASKYN treatment pathway, obtain resources, and get answers to your questions.
ZEVASKYN Treatment
Pathway
Coverage Review and Financial Assistance*
Travel and Logistical
Support*
*Eligibility requirements apply
Rely on Support at
Every Step
Embarking on a new treatment journey can feel like a big step. Abeona Assist can help you by pairing you with a Patient Navigator who will:
- Provide you with resources to support communication with your care team
- Guide you through the Abeona support offerings
- Tailor support to meet you and your caregiver’s specific needs
- Identify additional resources that may be available to you
Navigate your ZEVASKYN treatment
journey with Abeona Assist.
ZEVASKYN is an autologous cell sheet-based gene therapy for the treatment of wounds for adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Abeona Assist provides information and support to individuals, caregivers, and healthcare professionals throughout the following steps along the ZEVASKYN treatment journey.
Identify a Qualified Treatment Center (QTC)
ZEVASKYN Treatment Planning with a QTC Physician
Biopsy & ZEVASKYN Therapy Manufacturing
ZEVASKYN Surgical Application at QTC
We’re here to help.
Call Us at 855-ABEONA-1 (855-223-6621)
Our regular business hours are Monday-Friday 9 AM – 6:30 PM (ET)
You can also email us at MyNavigator@AbeonaAssist.com
Support is available 24/7 outside of normal business hours.
What is ZEVASKYN & Important Safety Information
What is ZEVASKYN?
ZEVASKYN™ (prademagene zamikeracel) is a type of gene therapy made from your own skin cells that is surgically applied to treat wounds in both children and adults who have recessive dystrophic epidermolysis bullosa (RDEB).
Important Safety Information
- Serious allergic reactions to ZEVASKYN can occur. Get medical help right away if you or your child experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen.
- There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works. Patients should be monitored for the rest of their lives to check for any signs of cancer.
- ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated.
- The most common side effects are pain from the procedure and itching.
This is not a complete list of side effects. Call your care team for medical advice about side effects. You may report side effects to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Post-Application Care
- You may feel pain or itching at the treated area as it heals. Contact your doctor if you have: fever, increased drainage, worsening pain or swelling, or any other symptoms at or near the treated area.
- Do not disturb the surgical dressing for 5–10 days, unless your doctor tells you otherwise.
- Keep the dressing(s) dry. Do not soak the treated area(s) in water (like in a bath or pool) until the gauze backing falls off of the treated area(s), approximately 2–3 weeks after the surgery.
Product Manufacturing
- ZEVASKYN is made from your own skin cells. In rare cases, the manufacturing process may not work. If this happens, your doctor may suggest taking another skin biopsy to repeat the manufacturing process.
Please see full Prescribing Information.